No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs546992769 |
chr2:74009707-74009708 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs116160950 |
chr2:74009712-74009713 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs536559945 |
chr2:74009758-74009759 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs73948197 |
chr2:74009760-74009761 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs548735635 |
chr2:74009770-74009771 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs536037202 |
chr2:74009802-74009803 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs114391430 |
chr2:74009812-74009813 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs72915474 |
chr2:74009817-74009818 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs559132531 |
chr2:74009821-74009822 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs374472740 |
chr2:74009827-74009828 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs182529123 |
chr2:74009864-74009865 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs377565210 |
chr2:74009870-74009871 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs534966855 |
chr2:74009876-74009877 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs143707486 |
chr2:74009905-74009906 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs139368859 |
chr2:74009914-74009915 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs373817348 |
chr2:74009931-74009932 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs554379008 |
chr2:74009968-74009969 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs572693929 |
chr2:74009971-74009972 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs145098867 |
chr2:74009974-74009975 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs576719478 |
chr2:74009977-74009978 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs539702863 |
chr2:74010014-74010015 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs147591913 |
chr2:74010016-74010017 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs577297446 |
chr2:74010019-74010020 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs114853152 |
chr2:74010022-74010023 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs141916109 |
chr2:74010026-74010027 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs201572527 |
chr2:74010048-74010049 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs558429916 |
chr2:74010051-74010052 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs116641217 |
chr2:74010056-74010057 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs540591271 |
chr2:74010065-74010066 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs559106239 |
chr2:74010066-74010067 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs530396499 |
chr2:74010125-74010126 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs187107100 |
chr2:74010138-74010139 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs539264115 |
chr2:74010141-74010142 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs576757137 |
chr2:74010154-74010155 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs548635162 |
chr2:74010155-74010156 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs190420297 |
chr2:74010165-74010166 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs531055385 |
chr2:74010193-74010194 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs552805490 |
chr2:74010207-74010208 |
Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs570916143 |
chr2:74010220-74010221 |
Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs181559778 |
chr2:74010227-74010228 |
Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs553383297 |
chr2:74010243-74010244 |
Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs2685277 |
chr2:74010265-74010266 |
Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
mRNA abundance
|
43 |
rs536540777 |
chr2:74010290-74010291 |
Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs185732010 |
chr2:74010293-74010294 |
Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs145481924 |
chr2:74010305-74010306 |
Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs543174942 |
chr2:74010306-74010307 |
Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs556647091 |
chr2:74010327-74010328 |
Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs190050800 |
chr2:74010359-74010360 |
Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs540754309 |
chr2:74010387-74010388 |
Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs577101243 |
chr2:74010397-74010398 |
Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|